Ibrutinib and Exforge drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ibrutinib (ibrutinib) and Exforge (amlodipine besylate; valsartan). Common drug interactions include cerebrovascular disorder among females and epistaxis among males.

The phase IV clinical study analyzes what interactions people have when they take Ibrutinib and Exforge. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Ibrutinib?

Ibrutinib has active ingredients of ibrutinib. eHealthMe is studying from 13,529 Ibrutinib users. Check the latest studies of Ibrutinib.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.



On Jul, 15, 2026

11 people who take Ibrutinib and Exforge together, and have interactions are studied.

Ibrutinib and Exforge drug interactions.

What are the common drug interactions of Ibrutinib and Exforge, by gender? *:

female:

  1. Cerebrovascular disorder (disease of brain)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Hypotension (abnormally low blood pressure)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Pneumonia
  6. Cardiac arrest

male:

  1. Epistaxis (bleed from the nose)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Interstitial lung disease
  4. Pericarditis (inflammation of the pericardium)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Large intestinal haemorrhage (bleeding in large intestine)
  7. Pulmonary congestion (congestion in the lungs)
  8. Haematoma (collection of blood outside the blood vessels)
  9. Type 2 diabetes mellitus

What are the common drug interactions of Ibrutinib and Exforge, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Interstitial lung disease
  2. Pericarditis (inflammation of the pericardium)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Type 2 diabetes mellitus

60+:

  1. Epistaxis (bleed from the nose)
  2. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  3. Haematoma (collection of blood outside the blood vessels)
  4. Cardiac arrest
  5. Cerebrovascular disorder (disease of brain)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Hypotension (abnormally low blood pressure)
  8. Large intestinal haemorrhage (bleeding in large intestine)
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Pneumonia

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 63.64%
  2. Diabetes: 4 people, 36.36%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 36.36%
  4. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 27.27%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 18.18%
  7. Constipation: 2 people, 18.18%
  8. Anaemia (lack of blood): 2 people, 18.18%
  9. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 9.09%
  10. Type 2 Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ibrutinib and Exforge?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ibrutinib and Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ibrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ibrutinib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ibrutinib and amlodipine besylate; valsartan (the active ingredients of Ibrutinib and Exforge, respectively), and Ibrutinib and Exforge (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: